chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Fever; chills/rigors; Severe myalgia; Nausea; vomiting; Severe headache; This is a spontaneous report from a contactable physician (patient). A 49-year-old female patient (no pregnancy) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), with first dose (lot number: ACEK5703) at 16:00 on 16Dec2020 and with second dose (lot number: EK9231) at 16:00 on 06Jan2021, both intramuscularly at site of left arm at single dose for COVID-19 immunization. Medical history reported none. The patient's concomitant medications were not reported. The patient experienced fever, chills, rigors, severe myalgia, nausea, vomiting, and severe headache at 01:00 AM on 07Jan2021. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No list of any other medications the patient received within 2 weeks of vaccination. The patient received treatment of paracetamol (TYLENOL) for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. No allergies to medications, food, or other products. This case was identified as non-serious by reporter. The outcome of events was recovered in Jan2021.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever; chills/rigors; Severe myalgia; Nausea; vomiting; Severe headache; This is a spontaneous report from a contactable physician (patient). A 49-year-old female patient (no pregnancy) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), with first dose (lot number: ACEK5703) at 16:00 on 16Dec2020 and with second dose (lot number: EK9231) at 16:00 on 06Jan2021, both intramuscularly at site of left arm at single dose for COVID-19 immunization. Medical history reported none. The patient's concomitant medications were not reported. The patient experienced fever, chills, rigors, severe myalgia, nausea, vomiting, and severe headache at 01:00 AM on 07Jan2021. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No list of any other medications the patient received within 2 weeks of vaccination. The patient received treatment of paracetamol (TYLENOL) for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. No known allergies. No allergies to medications, food, or other products. This case was identified as non-serious by reporter. The outcome of events was recovered in Jan2021.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy
Clinical narrative: Fatigue; lymph node swelling; This is a spontaneous report from a contactable nurse. A 52-year-old male patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown) intramuscular from 06Jan2021 10:45 to 06Jan2021 10:45 at single dose for COVID-19 vaccination. Medical history included idiopathic epilepsy. Concomitant medication included carbamazepine. On 06Jan2021 at 17:00, the patient had fatigue two days after as well lymph node swelling in armpit of arm where second dose administered. The patient also stated that with first dose from 15Dec2020 to 15Dec2020 for COVID-19 vaccination, the patient had soreness in his arm with no other symptoms. Outcome of the events was not recovered.  Information on the lot/ batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Coronavirus test, Pharyngeal swelling, Urticaria
Clinical narrative: throat began swelling up; hives; This is a spontaneous report from a contactable other HCP. A 30-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration from 06Jan2021 to 06Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history included known allergies: PCN. The patient's concomitant medications were not reported. On 06Jan2021, the patient stated that his throat began swelling up and also had breaking out into hives. The patient underwent lab tests and procedures which included nasal swab (COVID test): negative on 19Dec2020. Therapeutic measures were taken as a result of pharyngeal swelling and hives included Benadryl. Outcome of the events was not recovered.   Information on the Lot/batch number has been requested.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Malaise, Pyrexia, Vaccination site pain
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; This is a spontaneous report from a contactable Nurse.  A 49-year-old male received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number Ek5370 via an unspecified route of administration on 17Dec2020 15:00 at single dose (first dose) vaccine location=Left arm and lot number EL3246 on 05Jan2021 at single dose (second dose) vaccine location=Left arm for covid-19 immunisation. Patient age of vaccination is 48 years. Facility type vaccine: Hospital  The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension, gastrooesophageal reflux disease, erectile dysfunction, milk allergy and arthritis. Concomitant medication included colecalciferol (VITAMIN D [COLECALCIFEROL]), ibuprofen (MOTRIN [IBUPROFEN]), lisinopril (LISINOPRIL), paracetamol (TYLENOL), sildenafil (SILDENAFIL). On 06Jan2021 07:00 the patient developed chill, temperature of 99.6, body malaise, and pain at injection site. The patient recovered from events. in Jan2021 and no treatment was received. the action taken is not applicable.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Inappropriate schedule of product administration, Malaise, Pyrexia
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; This is a spontaneous report from a contactable Nurse.  A 49-year-old male received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number Ek5370 via an unspecified route of administration on 17Dec2020 15:00 at single dose (first dose) vaccine location=Left arm and lot number EL3246 on 05Jan2021 at single dose (second dose) vaccine location=Left arm for covid-19 immunisation. Patient age of vaccination is 48 years. Facility type vaccine: Hospital  The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension, gastrooesophageal reflux disease, erectile dysfunction, milk allergy and arthritis. Concomitant medication included colecalciferol (VITAMIN D [COLECALCIFEROL]), ibuprofen (MOTRIN [IBUPROFEN]), lisinopril (LISINOPRIL), paracetamol (TYLENOL), sildenafil (SILDENAFIL). On 06Jan2021 07:00 the patient developed chill, temperature of 99.6, body malaise, and pain at injection site. The patient recovered from events. in Jan2021 and no treatment was received. the action taken is not applicable.
Age: 48.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; This is a spontaneous report from a contactable Nurse.  A 49-year-old male received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number Ek5370 via an unspecified route of administration on 17Dec2020 15:00 at single dose (first dose) vaccine location=Left arm and lot number EL3246 on 05Jan2021 at single dose (second dose) vaccine location=Left arm for covid-19 immunisation. Patient age of vaccination is 48 years. Facility type vaccine: Hospital  The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included hypertension, gastrooesophageal reflux disease, erectile dysfunction, milk allergy and arthritis. Concomitant medication included colecalciferol (VITAMIN D [COLECALCIFEROL]), ibuprofen (MOTRIN [IBUPROFEN]), lisinopril (LISINOPRIL), paracetamol (TYLENOL), sildenafil (SILDENAFIL). On 06Jan2021 07:00 the patient developed chill, temperature of 99.6, body malaise, and pain at injection site. The patient recovered from events. in Jan2021 and no treatment was received. the action taken is not applicable.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Malaise, Pyrexia, Vaccination site pain
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; first dose on 17Dec2020 at 03:00 PM/ second dose on 05Jan2021; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) via an unspecified route of administration on left arm on 05Jan2021 at single dose for covid-19 immunisation. The relevant medical history included Hypertension, GERD (Gastroesophageal reflux disease), ED (Erectile dysfunction), arthritis, allergies to milk, all from an unspecified date. The patient received first dose of BNT162B2 (lot number: Ek5370), via Intramuscular on left arm on 17Dec2020 at 03:00 PM at single dose for covid-19 immunisation. Concomitant medications included lisinopril, ergocalciferol (VIT D), paracetamol (TYLENOL) for arthritis, sildenafil, ibuprofen (MOTRIN). The patient experienced chill, temp of 99.6, body malaise, pain at injection site on 06Jan2021 at 07:00 AM. The most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in Jan2021.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Inappropriate schedule of product administration, Malaise, Pyrexia
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; first dose on 17Dec2020 at 03:00 PM/ second dose on 05Jan2021; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) via an unspecified route of administration on left arm on 05Jan2021 at single dose for covid-19 immunisation. The relevant medical history included Hypertension, GERD (Gastroesophageal reflux disease), ED (Erectile dysfunction), arthritis, allergies to milk, all from an unspecified date. The patient received first dose of BNT162B2 (lot number: Ek5370), via Intramuscular on left arm on 17Dec2020 at 03:00 PM at single dose for covid-19 immunisation. Concomitant medications included lisinopril, ergocalciferol (VIT D), paracetamol (TYLENOL) for arthritis, sildenafil, ibuprofen (MOTRIN). The patient experienced chill, temp of 99.6, body malaise, pain at injection site on 06Jan2021 at 07:00 AM. The most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in Jan2021.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Chill; temp of 99.6; body malaise; pain at injection site; first dose on 17Dec2020 at 03:00 PM/ second dose on 05Jan2021; This is a spontaneous report from a contactable Nurse (patient). A 49-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) via an unspecified route of administration on left arm on 05Jan2021 at single dose for covid-19 immunisation. The relevant medical history included Hypertension, GERD (Gastroesophageal reflux disease), ED (Erectile dysfunction), arthritis, allergies to milk, all from an unspecified date. The patient received first dose of BNT162B2 (lot number: Ek5370), via Intramuscular on left arm on 17Dec2020 at 03:00 PM at single dose for covid-19 immunisation. Concomitant medications included lisinopril, ergocalciferol (VIT D), paracetamol (TYLENOL) for arthritis, sildenafil, ibuprofen (MOTRIN). The patient experienced chill, temp of 99.6, body malaise, pain at injection site on 06Jan2021 at 07:00 AM. The most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in Jan2021.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen Lymph Nodes; This is a spontaneous report from a contactable consumer. A20-year-male consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/lot number: EL1284 ) via an unspecified route of administration, on 07Jan2021 14:00 at a single dose, for COVID-19 immunization. Facility type vaccine: Military Base. Anatomical Location: Arm Left. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No patient's medical history reporter and concomitant medication included creatine monohydrate (CREATINE MONOHYDRATE). The patient experienced swollen lymph nodes on 07Jan2021 19:00 with outcome of not recovered.  he action taken was not applicable. No treatment was received.
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Tremor
Clinical narrative: right arm/hand/fingers began having generalized weakness and difficulty holding pen; mild tremors of the right hand and fingers; This is a spontaneous report from a contactable pharmacist. An adult female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot number: EJ1685, via an unspecified route of administration on 18Dec2020 (at an unspecified age) as a single dose for COVID-19 immunization. Medical history was not reported. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Concomitant medications were not reported. It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccination. On 18Dec2020, around 6 hours post-administration, the patient experienced right arm/hand/fingers generalized weakness and difficulty holding a pen as well as mild tremors of the right hand and fingers. This lasted approximately 45 minutes and resolved spontaneously. The side effects were reported to be mild and did not impact patient care duties. Treatment was not received for the events. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcomes of "right arm/hand/fingers generalized weakness and difficulty holding a pen" and "mild tremors of the right hand and fingers" were resolved on Dec2020.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Headache
Clinical narrative: Headache; Severe abdominal pains; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284) solution for injection, via an unspecified route of administration on left arm on 04Jan2021 14:45 at a single dose for COVID-19 immunization. Medical history included COVID-19 (patient was diagnosed with COVID-19 prior to vaccination). Patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient experienced severe abdominal pains on 06Jan2021 at 05:30, two days after taking vaccine that has lasted 3 days; and headache on 07Jan2021, the third day after getting the vaccine. No treatment was provided. The events were reported as non-serious. Outcome of the event severe abdominal pains was recovered on 08Jan2021 while headache was unknown.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Fatigue, Headache, Pain
Clinical narrative: chills; body ache; headache; fatigue; upper chest discomfort with deep breath; This is a spontaneous report from a contactable other health professional (patient herself). A 42-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EL3246), via an unspecified route of administration on 02Jan2021 11:00 in left arm at single dose for covid-19 immunization. The patient medical history was not reported. Allergies to medications, food, or other products was no. Concomitant medication included escitalopram oxalate (LEXAPRO, 10 mg) and vitamins nos (MULTIVITAMIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The most recent COVID-19 vaccine was administered in pharmacy or drug store. The patient experienced symptoms chills, body ache, mild headache, fatigue, and upper chest discomfort with deep breath on 06Jan2021. Patient never had a fever. Symptoms were resolved by the next day (07Jan2021).  No treatment was received for the events. All events were reported as non-serious.    No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Somnolence
Clinical narrative: tired; sleepy; nauseous; This is a spontaneous report from a contactable other Healthcare Professional (patient).  This 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 07Jan2021 at 7:00 at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. As of 08Jan2021, the patient reports she is now tired, sleepy, and nauseous. The events were reported as non-serious. Outcome was unknown. Information on the lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Upper arms soreness; This is a spontaneous report from a contactable other hcp. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date: unknown, intramuscular (right arm) on 16Dec2020 07:30 at a SINGLE DOSE then the second dose via intramuscular (left arm) on 06Jan2021 08:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient experienced upper arms soreness on an unspecified date with outcome of recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Back pain, Body temperature, Chills
Clinical narrative: Upper arms soreness; This is a spontaneous report from a contactable other hcp. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date: unknown, intramuscular (right arm) on 16Dec2020 07:30 at a SINGLE DOSE then the second dose via intramuscular (left arm) on 06Jan2021 08:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient experienced upper arms soreness on an unspecified date with outcome of recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disease recurrence, Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Upper arms soreness; This is a spontaneous report from a contactable other hcp. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date: unknown, intramuscular (right arm) on 16Dec2020 07:30 at a SINGLE DOSE then the second dose via intramuscular (left arm) on 06Jan2021 08:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient experienced upper arms soreness on an unspecified date with outcome of recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Upper arms soreness; This is a spontaneous report from a contactable other hcp. A 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date: unknown, intramuscular (right arm) on 16Dec2020 07:30 at a SINGLE DOSE then the second dose via intramuscular (left arm) on 06Jan2021 08:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. There were no concomitant medications.  The patient experienced upper arms soreness on an unspecified date with outcome of recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Upper arms soreness; Upper arms soreness; Chills; Headache; lower stomach and lower back cramping; lower back cramping; fever 102; Fatigue; joint and muscle pain; joint and muscle pain; This is a spontaneous report from a contactable Other Healthcare Professional (patient). A 39-year-old female patient (not pregnant) received the second dose of BNT162B2 (Pfizer BioNTech COVID-19 Vaccine), intramuscularly in left arm on 06Jan2021 08:00 AM at single dose for COVID-19 immunisation. Facility type vaccine was in hospital. Medical history included Sulfa allergy. There were no concomitant medications. The patient received the first dose of BNT162B2 on 16Dec2020 07:30 and experienced upper arms soreness. The patient didn't have other vaccine in four weeks or other medications in two weeks. The patient was not diagnosed with COVID-19 prior vaccination and didn't test COVID-19 post vaccination. After receiving the 2nd dose, the patient experienced upper arm soreness, chills, headache, lower stomach and lower back cramping, fever 102, fatigue, joint and muscle pain on 06Jan2021, 05:00 PM. No treatment was received for the events. Seriousness criteria was no. The outcome of the events was recovering.  Information about lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Back pain, Body temperature, Chills
Clinical narrative: Upper arms soreness; Upper arms soreness; Chills; Headache; lower stomach and lower back cramping; lower back cramping; fever 102; Fatigue; joint and muscle pain; joint and muscle pain; This is a spontaneous report from a contactable Other Healthcare Professional (patient). A 39-year-old female patient (not pregnant) received the second dose of BNT162B2 (Pfizer BioNTech COVID-19 Vaccine), intramuscularly in left arm on 06Jan2021 08:00 AM at single dose for COVID-19 immunisation. Facility type vaccine was in hospital. Medical history included Sulfa allergy. There were no concomitant medications. The patient received the first dose of BNT162B2 on 16Dec2020 07:30 and experienced upper arms soreness. The patient didn't have other vaccine in four weeks or other medications in two weeks. The patient was not diagnosed with COVID-19 prior vaccination and didn't test COVID-19 post vaccination. After receiving the 2nd dose, the patient experienced upper arm soreness, chills, headache, lower stomach and lower back cramping, fever 102, fatigue, joint and muscle pain on 06Jan2021, 05:00 PM. No treatment was received for the events. Seriousness criteria was no. The outcome of the events was recovering.  Information about lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disease recurrence, Fatigue, Headache, Myalgia, Pain in extremity
Clinical narrative: Upper arms soreness; Upper arms soreness; Chills; Headache; lower stomach and lower back cramping; lower back cramping; fever 102; Fatigue; joint and muscle pain; joint and muscle pain; This is a spontaneous report from a contactable Other Healthcare Professional (patient). A 39-year-old female patient (not pregnant) received the second dose of BNT162B2 (Pfizer BioNTech COVID-19 Vaccine), intramuscularly in left arm on 06Jan2021 08:00 AM at single dose for COVID-19 immunisation. Facility type vaccine was in hospital. Medical history included Sulfa allergy. There were no concomitant medications. The patient received the first dose of BNT162B2 on 16Dec2020 07:30 and experienced upper arms soreness. The patient didn't have other vaccine in four weeks or other medications in two weeks. The patient was not diagnosed with COVID-19 prior vaccination and didn't test COVID-19 post vaccination. After receiving the 2nd dose, the patient experienced upper arm soreness, chills, headache, lower stomach and lower back cramping, fever 102, fatigue, joint and muscle pain on 06Jan2021, 05:00 PM. No treatment was received for the events. Seriousness criteria was no. The outcome of the events was recovering.  Information about lot/batch number has been requested.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Upper arms soreness; Upper arms soreness; Chills; Headache; lower stomach and lower back cramping; lower back cramping; fever 102; Fatigue; joint and muscle pain; joint and muscle pain; This is a spontaneous report from a contactable Other Healthcare Professional (patient). A 39-year-old female patient (not pregnant) received the second dose of BNT162B2 (Pfizer BioNTech COVID-19 Vaccine), intramuscularly in left arm on 06Jan2021 08:00 AM at single dose for COVID-19 immunisation. Facility type vaccine was in hospital. Medical history included Sulfa allergy. There were no concomitant medications. The patient received the first dose of BNT162B2 on 16Dec2020 07:30 and experienced upper arms soreness. The patient didn't have other vaccine in four weeks or other medications in two weeks. The patient was not diagnosed with COVID-19 prior vaccination and didn't test COVID-19 post vaccination. After receiving the 2nd dose, the patient experienced upper arm soreness, chills, headache, lower stomach and lower back cramping, fever 102, fatigue, joint and muscle pain on 06Jan2021, 05:00 PM. No treatment was received for the events. Seriousness criteria was no. The outcome of the events was recovering.  Information about lot/batch number has been requested.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea
Clinical narrative: upset stomach; mild diarrhea; This is a spontaneous report from a contactable other hcp. A 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number=ej1686 and expiry date unknown, intramuscular (right arm) on 05Jan2021 14:00 at a SINGLE DOSE for covid-19 immunisation. Medical history included breast cancer from an unknown date and unknown if ongoing and drug hypersensitivity to Cipro from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took ciprofloxacin. The patient experienced upset stomach and mild diarrhea (non-serious) on 06Jan2021 22:00. The outcome of the events was recovering.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site soreness; This is a spontaneous report from a contactable other healthcare professional (patient). A 22-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) intramuscular at the right arm on 16Dec2020 11:00 at single dose for Covid-19 immunization in a hospital facility. Medical history included allergies to latex. The patient has no covid prior vaccination. The patient was not pregnant. Concomitant medications was none. The patient has no other vaccine in four weeks. The patient experienced injection site soreness on unspecified date. The patient did not receive treatment due to the event. The patient was not covid tested post vaccination. The reporter considered the event non-serious; which did not result in death, not life threatening, did not cause/prolong hospitalization, not disabling/incapacitating and no congenital anomaly/birth defect.  Follow-up activities are possible, information on the batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea
Clinical narrative: very dizzy; diarrhea; nausea; This is a spontaneous report from a contactable consumer (patient husband).   A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient got very dizzy and had diarrhea and nausea and today (08Jan2021), it is worse. Outcome was not recovered. Information about Lot/Batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Middle insomnia, Myalgia, Pyrexia
Clinical narrative: Severe joint and muscle pain; Severe joint and muscle pain; It woke me up; 99.8 with a gram of Tylenol on board; This is a spontaneous report from a non-contactable nurse, the patient.  A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included sertraline, cefixime (FLEXERIL), and paracetamol (TYLENOL). The patient did not receive any other vaccine within 4 weeks prior to the vaccination. On 07Jan2021 01:00 AM, the patient experienced severe joint and muscle pain. The patient was woken up even after taking cefixime which usually knocks the patient out (as reported). The patient had a temperature of 99.8 with a gram of paracetamol on board (as reported). The patient reported that she did not receive any treatment for the events. Since vaccination, the patient had not been tested for COVID-19. The outcome of the events severe joint, muscle pain, was woken and temperature of 99.8, were all recovering.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: body aches; Chills; low grade fever; This is a spontaneous report from a contactable consumer. A 45-year-old female patient started to receive bnt162b2 (BNT162B2, lot number EK9231), intramuscular (left deltoid) from 06Jan2021 08:30 to 06Jan2021 08:30 at 0.3 mL, single for covid-19 vaccination. Medical history included ongoing asthma. The patient also received first dose of bnt162b2 on 16Dec2020. Concomitant medication included budesonide, formoterol fumarate (SYMBICORT) and salbutamol sulfate (ALBUTEROL); both ongoing given for asthma. It was reported that the patient received the second Pfizer covid19 vaccine dose yesterday around 8:30am. She is calling to report that she experienced body aches, chills, and a low-grade fever which all started around 8pm yesterday (06Jan2021). For the treatment, she is taking Tylenol. The outcome of the events was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Parosmia
Clinical narrative: sensed/tasted metallic; sensed/tasted metallic; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot EK9231) solution for injection in the left arm on 05Jan2021 at 16:15 (at the age of 46-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included hypertensive. Concomitant medications included metoprolol; ascorbic acid/herbal nos/levoglutamide/lysine/magnesium/manganese/retinol/riboflavin/selenium/tocopherol/zinc (AIRBORNE); and an unspecified diuretic. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 05Jan2021 at 16:30, the patient experienced sensed/tasted metallic. The patient stated, "Immediately after the vaccine was injected, I sensed/tasted metallic. It has been four days since the injection and I still have the metallic taste." No treatment was provided for the event sensed/tasted metallic. The outcome of the event sensed/tasted metallic was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: when I stand up or walk, I become dizzy; This is a spontaneous report from a contactable health care professional, the patient. A 39-years-old male patient (health care professional) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ek9231), intramuscular in the left arm on 06-JAN-2021 12:45 as a single dose, for COVID-19 vaccination.  The vaccine was administered at a hospital. Medical history includes drug hypersensitivity to sulfa drugs.  There were no concomitant medications. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 07-JAN-2021 03:00, the patient experienced when I stand up or walk, I become dizzy. No treatment was given for the event. The clinical outcome of when I stand up or walk, I become dizzy was not recovered.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, SARS-CoV-2 test
Clinical narrative: Chills; Weakness; Headache; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received bnt162b2 (BNT162B2 reported as Pfizer BioNTech COVID 19 vaccine; lot number: EJ1688; expiration date: unknown), intramuscular injection in left deltoid on 04Jan2021 16:00 at a single dose for preventative (covid-19 vaccination). The patient has no medical history and concomitant medications. The patient reported that he received Pfizer BioNTech COVID 19 vaccine in a hospital on 04Jan2020 at 16:00. He started experiencing chills, weakness, and a headache two days (06Jan2021) after he was administered the vaccine. The patient did not received treatment. He mentioned that he went to a physician office since he did go to urgent care and was just told not to go back to work and stay home for 2 days. The doctor from urgent care he saw this morning (unspecified date) said he would send the notes to his primary doctor when querying dose and the patient mentioned he thinks he was told the dose was 1 cc, but he is not sure. He had a COVID PCR test this morning and he does not have results yet. He wanted to get permission to go back to work. The patient underwent lab tests and procedures which included COVID PCR test was unknown result on Jan2021. The patient did not have additional vaccines administered on the same date of the Pfizer Suspect. The outcome of the event weakness was not recovered while the outcome of the other events was recovering.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain, Pyrexia
Clinical narrative: Fever (T-max 100.4); headache; body aches; This is a spontaneous report from a contactable health care professional, the patient. A 29-years-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL1284) in the left arm on 07Jan2021  as a single dose, for COVID-19 vaccination.  The vaccine was administered at a Hospital.  Medical history included  Stiff-man syndrome, polycystic ovarian syndrome and known allergies to soy, sesame, and walnuts.  Concomitant medication included tramadol (TRAMADOL), gabapentin (GABAPENTIN), methocarbamol (ROBAXIN), dienogest, estradiol valerate (NATAZIA), insulin (INSULIN).  The patient previously experienced  drug hypersensitivity to Penicillin, Neosporin, and Levaquin. The patient received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EH9899), in the left arm on 17Dec2020 11:AM.  No other vaccines were given within 4 weeks except the first dose of BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 07Jan2021 17:30, the patient experienced fever (t-max 100.4), headache and body aches.  Lab data include body temperature: t-max 100.4 on 07Jan2021. No treatment was given for the events. The clinical outcome of the events fever (t-max 100.4), headache and body aches was recovering.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bone pain, Breast pain, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered.   Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Herpes zoster, Laboratory test
Clinical narrative: pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered.   Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Myalgia, Neck pain, Pain in extremity, Rash
Clinical narrative: pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered.   Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Spinal pain
Clinical narrative: pain/excruciating pain in her bones, and all over her body; pain in her bones; under her arm was swollen; under her arm was swollen and very painful; having pain in her breast; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got her second COVID vaccine shot on 07Jan2021, and was in pain and under her arm was swollen and very painful and she was having pain in her breast as well. Patient was in excruciating pain in her bones, and all over her body. Caller was taking paracetamol (TYLENOL) but that didn't help too much. Outcome of all events was not recovered.   Information about batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Inflammation, Vaccination site erythema, Vaccination site induration
Clinical narrative: whole upper arm redness and swelling/arm redness at the injection site; whole upper arm redness and swelling/inflamed swelling to her upper arm; arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration; whole upper arm redness and swelling/inflamed swelling to her upper arm; This is a spontaneous report from a contactable physician.  A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  via an unspecified route of administration on 06Jan2021 as a single dose in the arm for COVID-19 vaccination.  Medical history and concomitant medications were not reported. On 07Jan2021, the patient experienced whole upper arm redness and swelling following administration of BNT162B2. On 07Jan2021, she began having arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration. It was reported that no, the patient has whole upper arm redness and inflamed swelling to her upper arm. It was reported that the side effect is a very swollen red arm, all around the arm, it is very indurated all the way around her arm. The clinical outcome of whole upper arm redness and swelling/arm redness at the injection site and arm redness at the injection site, about 10cm-12cm in size, became a baseball size in diameter with redness and induration was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Pyrexia
Clinical narrative: Developed fever 102.7 F; Chills; Extreme weakness; This is a spontaneous report from a contactable healthcare professional who reported for himself, a 62-year-old male patient who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL0140) at the hospital, via an unspecified route of administration in the left arm on 07Jan2021 09:00 at a single dose for COVID-19 immunization. Medical history included CVA no residual, patent foramen ovale and known allergies to iodine. Concomitant medications included apixaban (ELIQUIS) and atorvastatin (ATORVASTATIN). Patient did not receive other vaccines in four weeks. On 08Jan2021 at 06:00 AM, the patient developed fever 102.7 F, chills and extreme weakness. Treatment for the events included Tylenol, tepid bath and "cleep". Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as non-serious. The outcome of the events was not recovered.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: woke up with Mild chills; body aches for 12 hours; This is a spontaneous report from a contactable other healthcare professional, the patient.  A 54-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  lot number: EH9899, via intramuscular on 06Jan2021 at 07:30 (at the age of 54 years old) as a single dose in the left arm for COVID-19 vaccination.  Medical history included enlarged prostate from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included tamsulosin, Vitamin D-3, Vitamin C, and montelukast sodium (SINGULAIR), all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination, but did receive the first dose of BNT162B2 with lot number: EH9899 on 16Dec2020 at 16:30, intramuscular in left arm. The vaccine was given at a hospital. On 07Jan2021 at 06:00, the patient woke up with mild chills, and body aches for 12 hours. The patient did not receive treatment for the events. The clinical outcome of mild chills, and body aches for 12 hours was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Feeling cold, Headache, Injection site pain
Clinical narrative: Arm soreness; Huge headache; Low grade fever (99.5); Felt cold, couldn't get warm; chills; Stabbing, shooting pain in right parotid glands; General feeling of unwellness; This is a spontaneous report from a contactable nurse. A 54-years-old female patient started to the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot EL0142, on 06Jan2021 (at the age of 54-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included chronic granulomatous disease. Concomitant medication were unspecified. The patient previously received the  first dose of BNT162B2, Lot number: EK5730, on 17Dec2020, administration time: 08:00 AM, in the left arm for covid-19 immunization. The patient previously took Oxacillin and Levaquin and experienced allergies. The most recent COVID-19 vaccine was administered in the workplace clinic. The patient was not pregnant at the time of vaccination.   Prior to vaccination, the patient was not diagnosed with COVID-19. On 07Jan2021 09:30, the patient experienced arm soreness, huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellnessThe events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events. Outcome of the events arm soreness, Huge headache, Low grade fever (99.5), Felt cold, couldn't get warm, chills, Stabbing, shooting pain in right parotid glands and General feeling of unwellness was recovered. Since the vaccination, the patient has not been tested for COVID-19.